Morten Orebo Holmström

Medicine & Life Sciences

1. Alleles 9%
2. Antibodies 7%
3. Antigens 15%
4. Arginase 41%
5. B-Cell Chronic Lymphocytic Leukemia 6%
6. Blood Platelets 10%
7. Bone Marrow 7%
8. Calnexin 9%
9. Calreticulin 100%
10. Cancer Vaccines 15%
11. Cancer-Associated Fibroblasts 7%
12. Cellular Immunity 7%
13. Epitopes 25%
14. Essential Thrombocythemia 8%
15. Exons 27%
16. Follicular Lymphoma 11%
17. Galectin 3 8%
18. Genes 8%
19. Hematologic Neoplasms 20%
20. Hematopoiesis 7%
21. Immunoglobulin Heavy Chains 8%
22. Immunosuppressive Agents 9%
23. INCB018424 23%
24. Indoleamine-Pyrrole 2,3,-Dioxygenase 8%
25. Interferon-alpha 14%
26. Interferons 16%
27. Ligands 18%
28. Major Histocompatibility Complex 8%
29. Mutation 42%
30. Neoplasms 69%
31. Nivolumab 8%
32. Organoids 8%
33. Pancreatic Neoplasms 18%
34. Peptides 35%
35. Philadelphia Chromosome 10%
36. Platelet Count 6%
37. Polycythemia Vera 14%
38. Preclinical Drug Evaluations 7%
39. Primary Myelofibrosis 40%
40. Regulatory T-Lymphocytes 8%
41. SARS Virus 9%
42. Subunit Vaccines 25%
43. T-Lymphocytes 80%
44. Therapeutics 18%
45. Thrombocytopenia 7%
46. Tissue Donors 15%
47. Transforming Growth Factors 13%
48. Tumor Microenvironment 21%
49. Vaccination 47%
50. Vaccines 33%